Clinical trial · Interventional
Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention
NCT01096134CI-TRIAL-00019446MDIcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The Mother-Daughter Initiative (MDI) will test the feasibility and acceptability of a strategy to deliver comprehensive cervical cancer prevention services in Thailand and the Philippines by integrating the HPV vaccine for girls ages 9-13 into already successful screening and treatment programs for mothers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HPV Vaccine (Gardasil) | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- HPV Vaccine
- description
- Eligible girls were offered 3 doses of the HPV vaccine
- interventionNames
- Biological: HPV Vaccine (Gardasil)
Primary outcomes (1)
- measure
- Determine the population coverage of HPV vaccination of girls aged 9-13 offered within the context of cervical cancer screening and treatment of mothers
- timeFrame
- 18 months
- description
- The aim of the study to assess whether we can fully vaccinate (all 3 doses),50% of girls aged 9 -13 in the participating districts, in an 18-month period. This corresponds to 4000 girls in Thailand and 4000 in Phillipines. The study will seek to undertand if this level of population coverage (50%), can be achieved through encouraging women that recive cervical cancer screening to bring in their daughters or relatives for vaccination.
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 9 Years
- Maximum age
- 13 Years
Show eligibility criteria text
Inclusion Criteria: * Age 9-13 at first HPV vaccine dose * Mother/legal guardian and daughter are both interested and willing to have the girl receive the HPV vaccine * Mother/legal guardian and daughter both indicate that they would be able to return to clinic for the three vaccine doses Exclusion Criteria: * Girls with a known history of any allergies or severe reaction to any vaccines, food or medicine * Pregnant adolescents will be excluded. If a girl becomes pregnant after the first dose is administered, she will not be provided with the second or third dose * Girls with moderate or severe illnesses will be asked to postpone vaccination eg. Pneumonia. * Girls with a weakened immune system, cancer, leukemia, AIDS or other immune system problems * Girls with a bleeding disorder or currently taking anticoagulants * Girls that have received any other vaccinations in the past 4 weeks * Girls currently on steroids, such as cortisone, prednisone, or anti-cancer drug.
References
Publications (0)
Data not yet available
No reference posted for this study.